目的:本研究采用Meta分析方法,系统评估了COVID‐19患者外周血中TH1、TH2、TH17相关细胞因子水平,并深入探讨了这些细胞因子研究结果存在差异的原因。方法:本研究已通过国际荟萃分析INPLASY平台认证(INPLASY协议认证编号:202380023),通...目的:本研究采用Meta分析方法,系统评估了COVID‐19患者外周血中TH1、TH2、TH17相关细胞因子水平,并深入探讨了这些细胞因子研究结果存在差异的原因。方法:本研究已通过国际荟萃分析INPLASY平台认证(INPLASY协议认证编号:202380023),通过检索中国知网、PubMed、Embase、Cochrane和Web of Science数据库,收集COVID-19患者和健康对照群体外周血TH1、TH2、TH17相关细胞因子(TNF-a、IL-2、IL-4、IL-10、IL-17)水平的病例对照研究,检索时间范围为建库至2023年10月10日。由研究者独立完成文献筛选、数据提取和偏倚评估,使用RevMan 5.4软件进行Meta分析。结果:该Meta分析共检索出19,941项研究,最终纳入了6项进行Meta分析,这些研究均为中、高质量文献。患者入组的时间范围从2020年~2022年不等。结果表明:COVID-19感染组的患者外周血TNF-a水平显著高于健康对照组(HC组) [MD = 3.42, 95%CI (1.91, 4.92), I2 = 50%, P 2 = 98%, P = 0.0004];COVID-19感染组患者外周血IL-10水平显著高于健康对照组(HC组) [MD = 3.38, 95%CI (1.97, 4.80), I2 = 84%, P 2 = 98%, P = 0.009];COVID-19感染组患者与HC组外周血IL-2水平差异无统计学意义[MD = 0.89, 95%CI (−2.19, 3.97), I2 = 67%, P = 0.57]。结论:一些与TH1、TH2及TH17相关的细胞因子在COVID-19患者外周血中的水平明显高于健康对照组,这些细胞因子在新型冠状病毒感染的疾病进展中起着重要作用。Objective: In this study, we used Meta-analysis to systematically evaluate the levels of TH1, TH2, and TH17-related cytokines in the peripheral blood of COVID-19 patients, and the reasons for the differences in the findings of these cytokines were explored in depth. Methods: This study has been validated by the international Meta-analysis INPLASY platform (INPLASY protocol certification number: 202380023), by searching China Knowledge, PubMed, Embase, Cochrane and Web of Science databases, a case-control study on the levels of TH1, TH2, and TH17-related cytokines (TNFa, IL-2, IL-4, IL-10, and IL-17) in peripheral blood of COVID-19 patients and healthy control groups was collected, with a search timeframe from library construction to October 10, 2023. Literature screening, data extraction and bias assessment were done independently by the authors, and Meta-analysis was performed using RevMan 5.4 software. Results: The Meta-analysis retrieved a total of 19,941 studies, and 6 were finally included for Meta-analysis, which were all medium- and high-quality literature. The time of patient enrollment ranged from 2020 to 2022. The results showed that patients in the COVID-19-infected group had significantly higher peripheral blood TNF-a levels than in the healthy control group (HC group) [MD = 3.42, 95%CI (1.91, 4.92), I2 = 50%, P 2 = 98%, P = 0.0004];peripheral blood IL-10 levels were significantly higher in patients in the COVID-19-infected group than in the healthy control group (HC group) [MD = 3.38, 95%CI (1.97, 4.80), I2 = 84%, P 2 = 98%, P = 0.009];the difference in peripheral blood IL-2 levels between patients in the COVID-19-infected group and the HC group was not statistically significant [MD = 0.89, 95%CI (−2.19, 3.97), I2 =67%, P = 0.57]. Conclusion: Some cytokines related to TH1, TH2 and TH17 were significantly higher in the peripheral blood of COVID-19 patients than in the healthy control group, and these cytokines play an important role in the disease progression of novel coronavirus infections.展开更多
目的·观察血清Th17/Treg水平的变化对阿尔茨海默病与牙周炎的影响。方法·纳入2020年6月—2021年12月就诊于上海交通大学医学院附属精神卫生中心老年科共18位伴阿尔茨海默病的牙周炎患者与同时期就诊于上海交通大学医学院附属...目的·观察血清Th17/Treg水平的变化对阿尔茨海默病与牙周炎的影响。方法·纳入2020年6月—2021年12月就诊于上海交通大学医学院附属精神卫生中心老年科共18位伴阿尔茨海默病的牙周炎患者与同时期就诊于上海交通大学医学院附属第九人民医院共15位认知功能正常的牙周炎患者,检查并记录患者探诊深度(probing depth,PD)、附着丧失(clinical attachment loss,CAL)及探诊出血位点比例(percentage of bleeding on probing,BOP%)。使用酶联免疫吸附法检测血清中Th17相关细胞因子白细胞介素-6(interleukin-6,IL-6)、IL-17、IL-22及Treg相关细胞因子IL-4、IL-10、转化生长因子-β(transforming growth factor-β,TGF-β)水平。采用样本独立t检验比较2组牙周指标与细胞因子水平的差异,P<0.05表示差异具有统计学意义。结果·伴阿尔茨海默病的牙周炎患者PD(P=0.021)、CAL(P=0.023)及BOP%(P=0.018)均显著高于认知功能正常的牙周炎患者。伴阿尔茨海默病的牙周炎患者血清IL-6(P=0.010)、IL-17(P=0.022)、IL-22(P=0.031)水平均显著高于认知功能正常的牙周炎患者;同时,组中IL-4(P=0.002)及IL-10(P=0.049)、TGF-β(P=0.006)水平相较于认知功能正常的牙周炎患者显著降低。结论·伴阿尔茨海默病牙周炎患者的牙周状况比认知功能正常的牙周炎患者差,Th17相关促炎细胞因子升高,而Treg相关抗炎因子降低,说明牙周炎可能通过介导Th17/Treg相关的慢性炎症反应影响阿尔茨海默病的发生发展。展开更多
文摘目的:本研究采用Meta分析方法,系统评估了COVID‐19患者外周血中TH1、TH2、TH17相关细胞因子水平,并深入探讨了这些细胞因子研究结果存在差异的原因。方法:本研究已通过国际荟萃分析INPLASY平台认证(INPLASY协议认证编号:202380023),通过检索中国知网、PubMed、Embase、Cochrane和Web of Science数据库,收集COVID-19患者和健康对照群体外周血TH1、TH2、TH17相关细胞因子(TNF-a、IL-2、IL-4、IL-10、IL-17)水平的病例对照研究,检索时间范围为建库至2023年10月10日。由研究者独立完成文献筛选、数据提取和偏倚评估,使用RevMan 5.4软件进行Meta分析。结果:该Meta分析共检索出19,941项研究,最终纳入了6项进行Meta分析,这些研究均为中、高质量文献。患者入组的时间范围从2020年~2022年不等。结果表明:COVID-19感染组的患者外周血TNF-a水平显著高于健康对照组(HC组) [MD = 3.42, 95%CI (1.91, 4.92), I2 = 50%, P 2 = 98%, P = 0.0004];COVID-19感染组患者外周血IL-10水平显著高于健康对照组(HC组) [MD = 3.38, 95%CI (1.97, 4.80), I2 = 84%, P 2 = 98%, P = 0.009];COVID-19感染组患者与HC组外周血IL-2水平差异无统计学意义[MD = 0.89, 95%CI (−2.19, 3.97), I2 = 67%, P = 0.57]。结论:一些与TH1、TH2及TH17相关的细胞因子在COVID-19患者外周血中的水平明显高于健康对照组,这些细胞因子在新型冠状病毒感染的疾病进展中起着重要作用。Objective: In this study, we used Meta-analysis to systematically evaluate the levels of TH1, TH2, and TH17-related cytokines in the peripheral blood of COVID-19 patients, and the reasons for the differences in the findings of these cytokines were explored in depth. Methods: This study has been validated by the international Meta-analysis INPLASY platform (INPLASY protocol certification number: 202380023), by searching China Knowledge, PubMed, Embase, Cochrane and Web of Science databases, a case-control study on the levels of TH1, TH2, and TH17-related cytokines (TNFa, IL-2, IL-4, IL-10, and IL-17) in peripheral blood of COVID-19 patients and healthy control groups was collected, with a search timeframe from library construction to October 10, 2023. Literature screening, data extraction and bias assessment were done independently by the authors, and Meta-analysis was performed using RevMan 5.4 software. Results: The Meta-analysis retrieved a total of 19,941 studies, and 6 were finally included for Meta-analysis, which were all medium- and high-quality literature. The time of patient enrollment ranged from 2020 to 2022. The results showed that patients in the COVID-19-infected group had significantly higher peripheral blood TNF-a levels than in the healthy control group (HC group) [MD = 3.42, 95%CI (1.91, 4.92), I2 = 50%, P 2 = 98%, P = 0.0004];peripheral blood IL-10 levels were significantly higher in patients in the COVID-19-infected group than in the healthy control group (HC group) [MD = 3.38, 95%CI (1.97, 4.80), I2 = 84%, P 2 = 98%, P = 0.009];the difference in peripheral blood IL-2 levels between patients in the COVID-19-infected group and the HC group was not statistically significant [MD = 0.89, 95%CI (−2.19, 3.97), I2 =67%, P = 0.57]. Conclusion: Some cytokines related to TH1, TH2 and TH17 were significantly higher in the peripheral blood of COVID-19 patients than in the healthy control group, and these cytokines play an important role in the disease progression of novel coronavirus infections.
文摘目的·观察血清Th17/Treg水平的变化对阿尔茨海默病与牙周炎的影响。方法·纳入2020年6月—2021年12月就诊于上海交通大学医学院附属精神卫生中心老年科共18位伴阿尔茨海默病的牙周炎患者与同时期就诊于上海交通大学医学院附属第九人民医院共15位认知功能正常的牙周炎患者,检查并记录患者探诊深度(probing depth,PD)、附着丧失(clinical attachment loss,CAL)及探诊出血位点比例(percentage of bleeding on probing,BOP%)。使用酶联免疫吸附法检测血清中Th17相关细胞因子白细胞介素-6(interleukin-6,IL-6)、IL-17、IL-22及Treg相关细胞因子IL-4、IL-10、转化生长因子-β(transforming growth factor-β,TGF-β)水平。采用样本独立t检验比较2组牙周指标与细胞因子水平的差异,P<0.05表示差异具有统计学意义。结果·伴阿尔茨海默病的牙周炎患者PD(P=0.021)、CAL(P=0.023)及BOP%(P=0.018)均显著高于认知功能正常的牙周炎患者。伴阿尔茨海默病的牙周炎患者血清IL-6(P=0.010)、IL-17(P=0.022)、IL-22(P=0.031)水平均显著高于认知功能正常的牙周炎患者;同时,组中IL-4(P=0.002)及IL-10(P=0.049)、TGF-β(P=0.006)水平相较于认知功能正常的牙周炎患者显著降低。结论·伴阿尔茨海默病牙周炎患者的牙周状况比认知功能正常的牙周炎患者差,Th17相关促炎细胞因子升高,而Treg相关抗炎因子降低,说明牙周炎可能通过介导Th17/Treg相关的慢性炎症反应影响阿尔茨海默病的发生发展。
